Label Changes for:

Caduet (amlodipine besylate/atorvastatin calcium) tablets

July 2009

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2009

ADVERSE REACTIONS

The Atorvastatin Component of CADUET/Postintroduction Reports with Atorvastatin
  • hepatic failure
Hide
(web4)